MENU
Showcases Stock ranks Forex

Kadmon Holdings Inc. (KDMN)
4.5  0 (0%) 09-18 16:00
Open: 4.56 Pre. Close: 4.5
High: 4.6682 Low: 4.35
Volume: 4,752,702 Market Cap: 770M
Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company is headquartered in New York City, New York and currently employs 116 full-time employees. The firm is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases. Its product pipeline consists of KD025, Tesevatinib and KD034. The firm's other products include Ribasphere RibaPak, Ribasphere, Qsymia, Tetrabenazine and Valganciclovir. KD025 is an orally available, selective small molecule inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2), a molecular target in multiple autoimmune, fibrotic and neurodegenerative diseases. Tesevatinib is an oral tyrosine kinase inhibitor (TKI) designed to block key molecular drivers of tumor growth, metastases and drug resistance. KD034 is the Company's portfolio of enhanced formulations of trientine hydrochloride for the treatment of Wilson's disease.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 4.674 - 4.697 4.697 - 4.717
Low: 4.308 - 4.333 4.333 - 4.355
Close: 4.462 - 4.501 4.501 - 4.535
Stock Technical Analysis
Overall:     
Target: Six months: 5.89
One year: 6.88
Support: Support1: 4.37
Support2: 3.95
Resistance: Resistance1: 5.04
Resistance2: 5.89
Pivot: 4.41
Moving Averages: MA(5): 4.45
MA(20): 4.44
MA(100): 4.40
MA(250): 4.14
MACD: MACD(12,26): 0.04
Signal(12,26,9): 0.04
%K %D: %K(14,3): 50.54
%D(3): 46.65
RSI: RSI(14): 54.75
52-Week: High: 5.5
Low: 2.3
Change(%): 66.7
Average Vol(K): 3-Month: 233839
10-Days: 217875
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

KDMN has closed below upper band by 40.8%. Bollinger Bands are 10.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Fri, 18 Sep 2020
Kadmon Holdings Inc. (KDMN) is on the roll with an average volume of 2.46M in the recent 3 months - investchronicle.com

Wed, 16 Sep 2020
Hedge Funds Keep Buying Kadmon Holdings, Inc. (KDMN) - Yahoo Finance

Mon, 14 Sep 2020
Kadmon Holdings Inc. (KDMN) recent quarterly performance of -8.10% is not showing the real picture - News Daemon

Fri, 11 Sep 2020
Who Has Been Buying Kadmon Holdings, Inc. (NYSE:KDMN) Shares? - Yahoo Finance

Thu, 10 Sep 2020
Kadmon Holdings Inc. [KDMN] fell -6.18% so far this year. What now? - The DBT News

Thu, 10 Sep 2020
Analysts Say Kadmon Holdings, Inc. (NYSE:KDMN) Can Really Get to $25 in 12 Months - Marketing Sentinel

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 171.14
Shares Float (M) 139.47
% Held by Insiders 0.16
% Held by Institutions 83.14
Shares Short (K) 27460
Shares Short Prior Month (K) 26180
Stock Financials
EPS -0.892
Book Value (p.s.) 0.700
Profit Margin
Operating Margin -715.86
Return on Assets (ttm) -24.6
Return on Equity (ttm) -85.8
Qtrly Rev. Growth 853.8
Gross Profit (p.s.) 0.022
Sales Per Share 0.069
EBITDA (p.s.) -0.486
Qtrly Earnings Growth
Operating Cash Flow (M) -73.67
Levered Free Cash Flow (M) -38.16
Stock Valuation
PE Ratio -5.04
PEG Ratio
Price to Book value 6.43
Price to Sales 65.21
Price to Cash Flow -10.45
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator